|
STT3B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.59889895662491E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.5933999675255E-09 |
| Normal-vs-Stage2 |
1.94623999999477E-05 |
| Normal-vs-Stage3 |
3.5527136788005E-14 |
| Normal-vs-Stage4 |
6.01099947594719E-10 |
| Stage1-vs-Stage2 |
7.150600E-01 |
| Stage1-vs-Stage3 |
4.995600E-03 |
| Stage1-vs-Stage4 |
6.445600E-02 |
| Stage2-vs-Stage3 |
2.524200E-02 |
| Stage2-vs-Stage4 |
7.670200E-02 |
| Stage3-vs-Stage4 |
9.342000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.12465592394528E-13 |
| Normal-vs-AfricanAmerican |
8.438000E-04 |
| Normal-vs-Asian |
2.33630000012752E-07 |
| Caucasian-vs-AfricanAmerican |
1.721170E-01 |
| Caucasian-vs-Asian |
5.815000E-01 |
| AfricanAmerican-vs-Asian |
4.070000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.45798994678171E-13 |
| Normal-vs-Female |
1.05599973210246E-10 |
| Male-vs-Female |
1.129630E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.38549998935412E-09 |
| Normal-vs-Age(41-60Yrs) |
1.90100157837492E-11 |
| Normal-vs-Age(61-80Yrs) |
9.37120381294676E-11 |
| Normal-vs-Age(81-100Yrs) |
2.243500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.843800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.611800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.605600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.216800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.120600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.763000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.62550000000406E-05 |
| Classical-VS-Follicular |
3.707200E-01 |
| Classical-VS-Other |
1.965040E-01 |
| Classical-VS-Normal |
2.4178992141799E-11 |
| Tall-VS-Follicular |
1.022780E-04 |
| Tall-VS-Other |
7.082400E-01 |
| Tall-VS-Normal |
6.10622663543836E-14 |
| Follicular-VS-Other |
1.943590E-01 |
| Follicular-VS-Normal |
2.29509999999378E-05 |
| Other-VS-Normal |
2.817100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.97250052034337E-10 |
| Normal-vs-N1 |
8.5773055324978E-11 |
| N0-vs-N1 |
4.817600E-02 |
|
|
